Liver Cirrhosis Network Cohort Study
Studying Autoimmune hepatitis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Northwestern University
- Principal Investigator
- Abigail SmithNorthwestern University
- Enrollment
- 1222 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2030
Study locations (14)
- University of California San Diego NAFLD Research Center, La Jolla, California, United States
- Keck Medical Center of USC, Los Angeles, California, United States
- LAC + USC Medical Center, Los Angeles, California, United States
- UCSF/Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States
- UCSF Medical Center, San Francisco, California, United States
- University of Miami Health System, Miami, Florida, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Mayo Clinic, Rochester, Minnesota, United States
- New York Presbyterian/Weill Cornell, New York, New York, United States
- Columbia University Iriving School of Medicine, New York, New York, United States
- Duke Liver Center, Durham, North Carolina, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Central Virginia Veterans Healthcare System, Richmond, Virginia, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
Collaborators
The Cleveland Clinic · Columbia University · Weill Medical College of Cornell University · Duke University · Mayo Clinic · University of Miami · University of Michigan · University of California, San Diego · University of California, San Francisco · LAC+USC Medical Center · Virginia Commonwealth University · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · National Cancer Institute (NCI) · University of Southern California · Central Virginia Veterans Healthcare System
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05740358 on ClinicalTrials.govOther trials for Autoimmune hepatitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07378202Machine Learning for Prediction of Therapy Response in Autoimmune HepatitisHannover Medical School
- RECRUITINGPHASE2NCT06381453Belimumab in Autoimmune HepatitisUniversity Health Network, Toronto
- RECRUITINGPHASE1NCT06455280A Study of SIPLIZUMAB in AILD and LT PatientsElizabeth C. Verna
- ENROLLING BY INVITATIONNCT06061341TruGraf Liver Gene Expression Serial TestWashington University School of Medicine
- RECRUITINGNCT06519162Liver-gut Axis Study Through Identification of Liver Disease-specific MicrobiomeChungnam National University Hospital
- RECRUITINGNANCT06250309Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis PatientsIndiana University
- RECRUITINGNCT05810480PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin GHannover Medical School
- RECRUITINGNCT06078098Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample StorageUniversity of Milano Bicocca